Loctek Ergonomic Technology Corp.: history, ownership, mission, how it works & makes money

From a 2002 start as a manufacturer of ergonomic furniture to a 2013 strategic pivot toward R&D and linear drive components, Loctek Ergonomic Technology Corp. (ChiNext: 300729.SZ) became the first A‑share company in health ergonomics with its December 1, 2017 IPO and has since scaled into a global player: by 2022 it reported revenue of 3.208 billion CNY and net income of 103 million CNY, its founders Xiang Lehong and Jiang Yi together control 49.01% of shares while Ningbo Lijing holds 21.29%, and strategic capital moves - including a 2023 plan to raise 500 million CNY for U.S. overseas warehouses - support an operating model built on a 700+ engineer R&D team, 1,287 patents (including 153 invention patents), four manufacturing plants across China and Vietnam totaling 450,000 m², over 100 new products annually, and dual brands LOCTEK and FlexiSpot (present in 30+ countries) that monetize through direct sales, e‑commerce, ODM/private‑label production and cross‑border logistics.

Loctek Ergonomic Technology Corp. (300729.SZ): Intro

• Founded in 2002 as a manufacturer of ergonomic furniture with an initial focus on height-adjustable desks and monitor arms.
• In 2013 the company formally shifted its primary business model to concentrate on research, development, production and sales of ergonomic products and linear drive components, representing a strategic transformation from pure manufacturing to technology-driven product lines.
• On December 1, 2017 Loctek was listed on the Shenzhen Stock Exchange ChiNext board (stock code 300729), becoming the first A-share listed company in the health ergonomics industry and the first cross-border e-commerce company to go public via an IPO on that board.
• By 2022, Loctek reported annual revenue of approximately 3.208 billion CNY and net income of about 103 million CNY, reflecting multi-year growth in scale and profitability driven by product diversification and expanded e-commerce channels.
• In 2023 Loctek announced a plan to raise 500 million CNY through stock issuance targeted at constructing overseas warehouses in the United States to strengthen its cross-border e-commerce supply chain and reduce delivery lead times.
• As of late 2025 the company continues global expansion with multiple manufacturing facilities in China and Vietnam and an expanded U.S. footprint through its subsidiary FlexiSpot, serving direct-to-consumer and channel partners.

• Loctek is a publicly traded A-share company (300729.SZ) with a shareholder base composed of founders/management, institutional investors, and public retail investors following the ChiNext IPO.
• Key operating subsidiaries include FlexiSpot (U.S. market subsidiary/brand) and manufacturing/assembly operations in China and Vietnam to support global supply chains and cross-border e-commerce.
• Corporate governance follows ChiNext listing rules with a board of directors, supervisory committee and periodic public disclosures of financials, major transactions and share issuance plans.

• Mission: design and deliver ergonomic, healthy work and living solutions that improve posture, comfort and productivity globally.
• Vision: be a global leader in ergonomics and linear motion technologies-bringing health-centric products to homes and offices worldwide.
• Core values: R&D-driven innovation, product quality, supply-chain efficiency, and customer-centric service.

• R&D: centralized technology and product development teams focus on ergonomic mechanisms (electric height-adjust systems, gas springs, monitor arms) and linear drive components.
• Manufacturing: vertically integrated production of mechanical components and final assembly across multiple plants in China and Vietnam to balance cost, capacity and lead times.
• Distribution & Sales Channels:
  • Cross-border e-commerce (own brands and channels, Amazon/marketplaces) - an early mover from China to global DTC marketplaces.
  • Wholesale/B2B and channel partnerships supplying office-furnishing dealers, retailers and corporate procurement.
  • Direct-to-consumer via FlexiSpot in the U.S., supported by planned/operating overseas warehouses to shorten delivery and returns cycles.
• After-sales & service: warranty, replacement parts and modular designs intended to extend product lifetime and capture aftermarket revenues.

• Product sales: primary revenue from ergonomic desks, electric lift systems, monitor arms, chair accessories and related components.
• Component sales and OEM: selling linear drive components and modules to other furniture and equipment manufacturers.
• Cross-border e-commerce margins: leveraging scale on platforms (marketplaces, own stores) plus logistics optimization via overseas warehouses to improve unit economics.
• Value-added services: extended warranties, spare parts, installation and B2B contract work.

• First-mover listed ergonomics firm in A-shares with strong cross-border e-commerce experience and an early shift into R&D-driven product portfolios.
• Vertical integration across component design and manufacturing supports cost control, customization and OEM opportunities.
• Expanded overseas logistics (warehouses in U.S.) aimed at reducing delivery times, returns cost and improving conversion on DTC channels.

• Capital raise (2023) allocated to U.S. overseas warehouses to strengthen cross-border fulfillment and service levels.
• Continued investment in R&D for linear drive technologies and new ergonomic product categories to capture both residential and commercial demand.
• Expansion of FlexiSpot brand presence in North America to convert marketplace scale into higher-margin direct sales and recurring aftermarket revenue.

Loctek Ergonomic Technology Corp. (300729.SZ): History

• Public listing: Shenzhen Stock Exchange, stock code 300729.SZ.
• Founding leadership: Founder & CEO Xiang Lehong remains a controlling influence alongside his wife Jiang Yi.
• Strategic capital moves: 2023 announcement to raise 500 million CNY via stock issuance to build overseas warehouses in the United States.
• Ongoing evolution: As of late 2025, stock performance and shareholder mix continue to shift with company strategy and market conditions.

• Ownership dynamics: The combined near-majority holding (49.01%) by Xiang Lehong and Jiang Yi provides strong founder control while Ningbo Lijing's 21.29% stake gives a sizable strategic partner position.
• Capital deployment: The 500 million CNY equity raise announced in 2023 signals focus on logistics infrastructure (U.S. warehouses) to support international sales and shorten delivery cycles.

Loctek Ergonomic Technology Corp. (300729.SZ): Ownership Structure

• Listing: Shenzhen ChiNext (stock code 300729.SZ)
• Shareholder composition: founders/management, institutions, retail investors
• Governance: board of directors, supervisory committee, independent directors

• Innovation: over 1,287 patents in total, including 153 invention patents; R&D team of over 700 engineers.
• Quality & Safety: routine batch testing and international certifications including CB, CE, ISO and UL.
• Global Expansion: manufacturing facilities in China and Vietnam and overseas warehouses in the United States to support cross-border e-commerce.
• Customer-centric Brands: products marketed under 'LOCTEK' and overseas brand 'FlexiSpot' to serve diverse markets.
• Sustainability: emphasis on eco-friendly materials and processes across product development and manufacturing.

Loctek Ergonomic Technology Corp. (300729.SZ): Mission and Values

• Vertical integration: in-house R&D, component fabrication, assembly and brand marketing to control quality and margins.
• Innovation-first culture: large R&D investment and rapid product iteration to address evolving ergonomic needs.
• Global customer focus: omni-channel distribution to serve both domestic China and international markets, supporting cross-border e-commerce.

• Manufacturing footprint: Four manufacturing plants located in China and Vietnam with a combined production area of 450,000 square meters provide scale and flexibility in production scheduling and SKU variety.
• R&D engine: A technical team of over 700 engineers develops more than 100 new products annually, underpinning product refresh cycles and IP creation.
• Quality & safety: In-house UL and GS certified laboratories perform product and shipping-condition testing to meet international safety standards and reduce returns/damage.
• Supply chain & logistics: Robust supply chain including overseas warehouses (notably in the United States) to shorten delivery lead times for cross-border e-commerce and B2B shipments.
• Brands & channels: Products marketed under LOCTEK (domestic) and FlexiSpot (overseas), sold via e-commerce platforms, marketplaces, direct B2B sales, and authorized distributors.

• Primary revenue drivers:
  • Standing desks and adjustable-height workstations (core category).
  • Monitor arms, ergonomic chairs and desktop accessories (adjacent accessories).
  • Contract and institutional sales (office fit-outs, corporate procurement).
  • Cross-border e-commerce channels (direct-to-consumer via marketplaces and brand stores).

• Capture of manufacturing margin: vertical integration reduces reliance on third-party OEMs and preserves margin across the value chain.
• Product lifecycle monetization: frequent new-product introductions and accessory bundles increase average order value and repeat purchases.
• Channel mix optimization: higher-margin direct sales and branded e-commerce complement volume-driven marketplace and distributor channels.
• Cost control via scale: large production area and multi-site capacity enable cost leverage on material procurement and labor allocation.

Loctek Ergonomic Technology Corp. (300729.SZ): How It Works

• Primary products: electric and manual height-adjustable desks, monitor arms, sit-stand converters, ergonomic accessories (keyboard trays, cable management, power modules).
• Dual-brand strategy: LOCTEK for domestic China channels; FlexiSpot for international e-commerce, retail and B2B markets.
• Sales channels: domestic distributors, cross-border e-commerce (Amazon, own sites), overseas warehouses, OEM/ODM and private-label contracts.
• Logistics & fulfillment: overseas warehouses (notably US facilities) to shorten delivery time, reduce returns and improve margins.

• Product sales: finished goods sold through LOCTEK/FlexiSpot and third-party retailers-largest single revenue source.
• Cross-border e-commerce: direct-to-consumer international sales via marketplaces and brand sites; higher ASPs and better gross margins due to brand positioning.
• ODM / private label manufacturing: steady B2B revenue from global OEM customers; leverages manufacturing scale and design capabilities.
• After-sales and accessories: recurring revenue from add-on products, spare parts and warranty/up-sell services.

• R&D & design: in-house product development for ergonomic mechanics, motor control and modularity that reduce BOM costs and support ODM offers.
• Manufacturing scale: centralized production in China with cost control, enabling competitive pricing for global markets.
• Overseas fulfillment footprint: planned and executed investments in US/overseas warehouses (including a planned ~500 million CNY investment in the United States) to cut lead times and logistics cost per order.
• Channel mix optimization: balancing marketplace growth (FlexiSpot) with traditional distribution (LOCTEK) to stabilize margins and risk.

• International brand (FlexiSpot) accounts for a large and growing portion of revenue; marketplace algorithms and advertising costs influence unit economics.
• ODM/private label contracts mitigate single-brand risk but may compress margins versus direct-brand sales.
• Logistics investment raises fixed costs but aims to lower per-order fulfillment expense and reduce return rates.

Loctek Ergonomic Technology Corp. (300729.SZ): How It Makes Money

• Primary revenue streams: direct product sales (electric standing desks, monitor arms, treadmill desks, ergonomic chairs), OEM/ODM manufacturing contracts, and online retail via own sites and marketplaces.
• Channel mix: domestic retail & distributors, FlexiSpot-operated overseas e-commerce and third‑party marketplaces, and B2B sales to corporate and institutional buyers.
• Geographic diversification: expanding export-led sales through overseas warehouses and regional distribution hubs.

• Monetization strategies tied to market position:
  • Premium product pricing backed by R&D and patented features.
  • Scale-driven manufacturing margins via in-house production and OEM contracts.
  • Higher ASPs in overseas markets through FlexiSpot branding and localized distribution.
• Competitive enablers:
  • Large patent portfolio (1,287 patents) supporting differentiated product features and licensing potential.
  • Planned capex (500M CNY in the U.S.) to speed delivery, reduce logistics costs and improve conversion in key markets.
  • Quality certifications and testing that reduce returns and enhance brand trust.